Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomised trial, JMIR

RCT (n=400) found patients with mild-to-moderate COVID-19 infection treated with ivermectin plus doxycycline recovered earlier vs placebo (61% vs 44% with ≤7-day recovery) and were less likely to progress to serious disease and more likely to be negative by RT-PCR on day 14.

Source: Current Awareness Service for Health (CASH) - May 26, 2021 Category: Consumer Health News Source Type: news